bintrafusp alfa

GSK, Merck KGaA's BTC Drug Fails for Second Time This Year
BioSpace
Tue, 03/16/21 - 10:51 pm
Merck KGaA
GSK
metastatic biliary tract cancer
bintrafusp alfa
GSK, German Merck's $4.2B bintrafusp alfa drug a bust, fails to beat king Keytruda in lung cancer
Fierce Biotech
Wed, 01/20/21 - 10:48 am
GSK
Merck KGaA
bintrafusp alfa
clinical trial
Merck
Keytruda